They found that the inhibition of PCSK9 enhanced the tumor response to PD-1 inhibitors by promoting massive infiltration of CTLs within the tumor through a mechanism independent of the cholesterol regulatory function of PCSK9 [55]. Here, PDCD1 is linked to neoplasm.